COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-01515-0001-0000-5
Chemical Name: 4-Nitro-o-phenylenediamine
CASRN: 99-56-9
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 549927_SCE
Study Result: Positive

Study Result: Positive
Activation Trial Trial Call
No Activation  Positive 
No Activation  Positive 
Induced Rat Liver S9  1_S9  Positive 
Induced Rat Liver S9  2_S9  Positive 

Trial #: 1    Activation: No Activation    Date: 05/01/1984    Trial Call: Positive   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Negative (Not Specified)
0         
50 1046 435 0.416 8.70 26.5 -4.332
Medium
0         
50 1049 456 0.435 9.12 26.5 0.000
Test Chemical 4-Nitro-o-phenylenediamine
1.6       
50 1045 593 0.567 11.86 26.0 30.542
5         
50 1048 670 0.639 13.40 26.0 47.070
16         
50 1049 816 0.778 16.32 26.0 78.947
50         
50 1047 1213 1.159 24.26 26.0 166.517
160         
0 0 0 0.000 0.00 26.0 N/A
Positive Control Mitomycin-C
 0.001     
50 1050 1302 1.240 26.04 26.5 185.254
Mitomycin-C
 0.01      
10 210 749 3.567 74.90 26.5 720.490
Trend: 20.056        
Probability: 0.000        

Trial #: 2    Activation: No Activation    Date: 05/30/1984    Trial Call: Positive   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Negative (Not Specified)
0         
50 1047 485 0.463 9.70 26.0 2.852
Dimethyl Sulfoxide
0         
50 1048 472 0.450 9.44 26.0 0.000
Test Chemical 4-Nitro-o-phenylenediamine
5         
50 1051 649 0.618 12.98 26.0 37.108
16         
50 1050 802 0.764 16.04 26.0 69.592
50         
50 1042 933 0.895 18.66 26.0 98.808
75         
16 336 352 1.048 22.00 26.0 132.607
100         
50 1046 1144 1.094 22.88 31.0 142.836
100         
0 0 0 0.000 0.00 26.0 N/A
200         
0 0 0 0.000 0.00 31.0 N/A
Positive Control Mitomycin-C
 0.001     
50 1051 1348 1.283 26.96 26.0 184.778
Mitomycin-C
 0.01      
10 210 612 2.914 61.20 26.0 547.070
Trend: 18.793        
Probability: 0.000        

Trial #: 1_S9    Activation: Induced Rat Liver S9    Date: 05/01/1984    Trial Call: Positive   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Negative (Not Specified)
0         
50 1046 440 0.421 8.80 26.0 -0.131
Dimethyl Sulfoxide
0         
50 1047 441 0.421 8.82 26.0 0.000
Test Chemical 4-Nitro-o-phenylenediamine
160         
50 1049 490 0.467 9.80 26.0 10.899
500         
50 1048 559 0.533 11.18 26.0 26.636
1600         
50 1044 602 0.577 12.04 26.0 36.900
5000         
50 1047 879 0.840 17.58 26.0 99.320
Positive Control Cyclophosphamide
 0.3       
50 1048 624 0.595 12.48 26.0 41.362
Cyclophosphamide
2         
10 210 340 1.619 34.00 26.0 284.386
Trend: 12.850        
Probability: 0.000        

Trial #: 2_S9    Activation: Induced Rat Liver S9    Date: 05/30/1984    Trial Call: Positive   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Dimethyl Sulfoxide
0         
50 1049 512 0.488 10.24 26.0 0.000
Negative (Not Specified)
0         
50 1048 471 0.449 9.42 26.0 -7.920
Test Chemical 4-Nitro-o-phenylenediamine
2000         
50 1047 643 0.614 12.86 26.0 25.826
3000         
50 1050 852 0.811 17.04 26.0 66.248
4000         
50 1050 856 0.815 17.12 26.0 67.028
5000         
50 1047 847 0.809 16.94 26.0 65.746
Positive Control Cyclophosphamide
 0.3       
50 1049 640 0.610 12.80 26.0 25.000
Cyclophosphamide
2         
10 210 378 1.800 37.80 26.0 268.789
Trend: 10.688        
Probability: 0.000